About Acme Bioscience
Acme Bioscience is a Healthcare company based in Palo Alto (United States) founded in 2001, and was acquired by Frontage Laboratories in July 2020. Medicinal and synthetic chemistry services. Acme Bioscience offers products and services including Discovery Chemistry, Medicinal Chemistry, Process Chemistry, and Chemical Manufacturing. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Medicinal Chemistry. Its legal entity is Acme Bioscience, Inc.
Company details
Acme Bioscience is a CRO offering medicinal and synthetic organic chemistry services for preclinical drug development. Their medicinal chemistry services include hit finding, hit-to-lead, and lead optimization while their custom synthesis services cater to APIs, building blocks, intermediates, reference compounds, metabolites, impurity markers, and chiral compounds, among others. They also offer their services for process development, scale-up, and regulatory CMC services. Through their partners they also offer in vitro and in vivo DMPK and custom manufacturing services.
- Headquarters Palo Alto, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website acmeca.com
- Social LinkedIn
- Acquired by Frontage Laboratories (Jul 2020)
- Legal Name Acme Bioscience, Inc.
- Investors
- Acquired byFrontage Laboratories
(Jul 2020)
Products & Services of Acme Bioscience
Acme Bioscience offers a comprehensive portfolio of products and services, including Discovery Chemistry, Medicinal Chemistry, Process Chemistry, and Chemical Manufacturing.
Supports early-stage drug discovery for biopharmaceutical clients.
Focuses on designing and optimizing chemical compounds for drugs.
Handles research and development for chemical production processes.
Provides services for synthesizing and manufacturing chemical entities.
Investors in Acme Bioscience
Acme Bioscience has secured backing from 1 investor. Prominent investors backing the company include Frontage Laboratories.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early drug development services are provided for pharma firms. | 2001 | frontagelab.com | Exton, United States |
Investor details for Acme Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Acme Bioscience
2 dated milestones of Acme Bioscience across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Acme Bioscience is founded.
- Exit Acquired by Frontage Laboratories.
Web traffic of Acme Bioscience
The website of Acme Bioscience (acmeca.com) receives about 1.4K visits a month.
- Monthly visits1.4K
▲ 126% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Acme Bioscience (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Acme Bioscience
Complete news archive for Acme Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Acme Bioscience
Acme Bioscience was founded in 2001.
Acme Bioscience is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Acme Bioscience is a CRO offering medicinal and synthetic organic chemistry services for preclinical drug development. Their medicinal chemistry services include hit finding, hit-to-lead, and lead optimization while their custom synthesis services cater to APIs, building blocks, intermediates, reference compounds, metabolites, impurity markers, and chiral compounds, among others. They also offer their services for process development, scale-up, and regulatory CMC services. Through their partners they also offer in vitro and in vivo DMPK and custom manufacturing services.
Acme Bioscience offers Discovery Chemistry, Medicinal Chemistry, Process Chemistry, and Chemical Manufacturing.
Acme Bioscience has 1 investor. Key investors include Frontage Laboratories.
Acme Bioscience operates through Acme Bioscience, Inc..
Yes. Acme Bioscience was acquired by Frontage Laboratories in July 2020.